Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Nature Communications|January 9, 2021
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative RhabdomyosarcomaSilvia Pomella, Prethish Sreenivas, Berkley E Gryder, et al.Cell Death & Disease|June 1, 2026
Multi-omics analyses identify EZH2 as a central driver in rhabdomyosarcoma radioresistance and highlight Tazemetostat as an effective radiosensitizer in vitro and in vivoMatteo Cassandri, Antonella Porrazzo, Simona Camero, et al.Cancer Discovery|April 28, 2017
PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain VulnerabilityBerkley E Gryder, Marielle E Yohe, Hsien-Chao Chou, et al.Cell Death Discovery|August 6, 2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaksMatteo Cassandri, Antonella Porrazzo, Silvia Pomella, et al.Journal of Hematology & Oncology|December 19, 2024
Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cellsMichele Pezzella, Concetta Quintarelli, Maria C Quadraccia, et al.Nature Communications|February 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Yean Kim, Berkley E Gryder, Ranuka Sinniah, et al.Nature Communications|December 15, 2023
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targetingSilvia Pomella, Matteo Cassandri, Lucrezia D'Archivio, et al.Cancers|March 28, 2026
Biological Advances and Current Challenges for Pediatric RhabdomyosarcomaKatie E Hebron, Patience Odeniyide, Yun Wei, et al.British Journal of Cancer|June 13, 2026
Paediatric Therapeutic Development Workshop on rhabdomyosarcomaJoseph S Baxter, Claudia Montiel Equihua, Jan J Molenaar, et al.Pageof 5